BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12457721)

  • 21. Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia.
    Pepper C; Thomas A; Hoy T; Fegan C; Bentley P
    Br J Haematol; 2001 Jul; 114(1):70-7. PubMed ID: 11472347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhabdoid tumor growth is inhibited by flavopiridol.
    Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV
    Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin-dependent kinase inhibitor, flavopiridol, induces apoptosis and inhibits tumor growth in drug-resistant osteosarcoma and Ewing's family tumor cells.
    Li Y; Tanaka K; Li X; Okada T; Nakamura T; Takasaki M; Yamamoto S; Oda Y; Tsuneyoshi M; Iwamoto Y
    Int J Cancer; 2007 Sep; 121(6):1212-8. PubMed ID: 17520676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP.
    Mantena SK; Sharma SD; Katiyar SK
    Carcinogenesis; 2006 Oct; 27(10):2018-27. PubMed ID: 16621886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
    Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D
    Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells.
    Motwani M; Li X; Schwartz GK
    Clin Cancer Res; 2000 Mar; 6(3):924-32. PubMed ID: 10741717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
    Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
    Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol.
    Shapiro GI
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4270s-4275s. PubMed ID: 15217973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
    Jung C; Motwani M; Kortmansky J; Sirotnak FM; She Y; Gonen M; Haimovitz-Friedman A; Schwartz GK
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6052-61. PubMed ID: 14676132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2.
    Dasmahapatra G; Almenara JA; Grant S
    Mol Pharmacol; 2006 Jan; 69(1):288-98. PubMed ID: 16219908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
    Aranha O; Wood DP; Sarkar FH
    Clin Cancer Res; 2000 Mar; 6(3):891-900. PubMed ID: 10741713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.
    Senderowicz AM; Headlee D; Stinson SF; Lush RM; Kalil N; Villalba L; Hill K; Steinberg SM; Figg WD; Tompkins A; Arbuck SG; Sausville EA
    J Clin Oncol; 1998 Sep; 16(9):2986-99. PubMed ID: 9738567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity In vivo against human leukemia and lymphoma xenografts.
    Arguello F; Alexander M; Sterry JA; Tudor G; Smith EM; Kalavar NT; Greene JF; Koss W; Morgan CD; Stinson SF; Siford TJ; Alvord WG; Klabansky RL; Sausville EA
    Blood; 1998 Apr; 91(7):2482-90. PubMed ID: 9516149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
    Singh RP; Agarwal C; Agarwal R
    Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small molecule modulators of cyclin-dependent kinases for cancer therapy.
    Senderowicz AM
    Oncogene; 2000 Dec; 19(56):6600-6. PubMed ID: 11426645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.
    Rideout HJ; Wang Q; Park DS; Stefanis L
    J Neurosci; 2003 Feb; 23(4):1237-45. PubMed ID: 12598612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferative effect of resveratrol in human prostate carcinoma cells.
    Kim YA; Rhee SH; Park KY; Choi YH
    J Med Food; 2003; 6(4):273-80. PubMed ID: 14977434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.